Clinical Trial Update: Frequent Hemodialysis Network: Daily Trial [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports that the Frequent Hemodialysis Network: Daily Trial, a Phase 2/3 study for end-stage renal disease, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: End Stage Renal Disease | Phase 2, Phase 3 | Status: COMPLETED